Proton MR Spectroscopy–Detectable Major Neurotransmitters of the Brain: Biology and Possible Clinical Applications

SUMMARY: Neurotransmitters are chemical substances that, by definition, allow communication between neurons and permit most neuronal-glial interactions in the CNS. Approximately 80% of all neurons use glutamate, and almost all interneurons use GABA. A third neurotransmitter, NAAG, modulates glutamatergic neurotransmission. Concentration changes in these molecules due to defective synthetic machinery, receptor expression, or errors in their degradation and metabolism are accepted causes of several neurologic disorders. Knowledge of changes in neurotransmitter concentrations in the brain can add useful information in making a diagnosis, helping to pick the right drug of treatment, and monitoring patient response to drugs in a more objective manner. Recent advances in 1H-MR spectroscopy hold promise in providing a more reliable in vivo detection of these neurotransmitters. In this article, we summarize the essential biology of 3 major neurotransmitters: glutamate, GABA, and NAAG. Finally we illustrate possible applications of 1H-MR spectroscopy in neuroscience research.

[1]  R. Bartha,et al.  Reduced hippocampal glutamate in Alzheimer disease , 2011, Neurobiology of Aging.

[2]  Merit Cudkowicz,et al.  ALS drug development: Reflections from the past and a way forward , 2008, Neurotherapeutics.

[3]  H. Johansen-Berg,et al.  Autoantibodies to glutamic acid decarboxylase in patients with epilepsy are associated with low cortical GABA levels , 2010, Epilepsia.

[4]  A. Doerfler,et al.  Alterations of intracerebral γ‐aminobutyric acid (GABA) levels by titration with levetiracetam in patients with focal epilepsies , 2010, Epilepsia.

[5]  P. Renshaw,et al.  Update on the use of MR for assessment and diagnosis of psychiatric diseases. , 2010, Radiology.

[6]  A. Doerfler,et al.  In vivo quantification of intracerebral GABA by single-voxel (1)H-MRS-How reproducible are the results? , 2010, European journal of radiology.

[7]  Jing Han,et al.  Study of the features of proton MR spectroscopy (1H‐MRS) on amyotrophic lateral sclerosis , 2010, Journal of magnetic resonance imaging : JMRI.

[8]  R. Bartha,et al.  Increased glutamate in the hippocampus after galantamine treatment for Alzheimer disease , 2010, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[9]  H. Biceroglu,et al.  The expression of astroglial glutamate transporters in patients with focal cortical dysplasia: an immunohistochemical study , 2010, Acta Neurochirurgica.

[10]  Ji-Kyung Choi,et al.  Magnetic resonance spectroscopy of regional brain metabolite markers in FALS mice and the effects of dietary creatine supplementation , 2009, The European journal of neuroscience.

[11]  Kenji Mori,et al.  High gamma-aminobutyric acid level in cortical tubers in epileptic infants with tuberous sclerosis complex measured with the MEGA-editing J-difference method and a three-Tesla clinical MRI Instrument , 2009, NeuroImage.

[12]  A. Sakamoto,et al.  Magnetic resonance spectroscopy reveals an epileptic network in juvenile myoclonic epilepsy , 2009, Epilepsia.

[13]  A. Rominger,et al.  PET and SPECT in epilepsy: A critical review , 2009, Epilepsy & Behavior.

[14]  G. Barker,et al.  Proton MR spectroscopy of metabolite concentrations in temporal lobe epilepsy and effect of temporal lobe resection , 2009, Epilepsy Research.

[15]  David Borsook,et al.  Excitatory neurotransmitters in brain regions in interictal migraine patients , 2009, Molecular pain.

[16]  O. Okonkwo,et al.  Brain metabolism differs in Alzheimer's disease and Parkinson's disease dementia , 2008, Alzheimer's & Dementia.

[17]  R. Prost,et al.  MR‐spectroscopic findings in juvenile‐onset Huntington's disease , 2008, Movement disorders : official journal of the Movement Disorder Society.

[18]  M. Baslow The astrocyte surface NAAG receptor and NAAG peptidase signaling complex as a therapeutic target. , 2008, Drug news & perspectives.

[19]  S. Santi,et al.  Memantine decreases hippocampal glutamate levels: A magnetic resonance spectroscopy study , 2008, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[20]  Christian Steinhäuser,et al.  Astrocytic function and its alteration in the epileptic brain , 2008, Epilepsia.

[21]  P. Pollak,et al.  Glutamate measurement in Parkinson's disease using MRS at 3 T field strength , 2007, NMR in biomedicine.

[22]  Ravi S. Menon,et al.  Longitudinal grey-matter and glutamatergic losses in first-episode schizophrenia , 2007, British Journal of Psychiatry.

[23]  P. Magistretti,et al.  Activity‐dependent regulation of energy metabolism by astrocytes: An update , 2007, Glia.

[24]  Morris H. Baslow,et al.  Using proton magnetic resonance imaging and spectroscopy to understand brain “activation” , 2007, Brain and Language.

[25]  F. Nicoletti,et al.  The Use of Knock-Out Mice Unravels Distinct Roles for mGlu2 and mGlu3 Metabotropic Glutamate Receptors in Mechanisms of Neurodegeneration/Neuroprotection , 2007, The Journal of Neuroscience.

[26]  K. Obata,et al.  Role of glutamate decarboxylase (GAD) isoform, GAD65, in GABA synthesis and transport into synaptic vesicles—Evidence from GAD65-knockout mice studies , 2007, Brain Research.

[27]  J. Moffett,et al.  Selective vulnerability of hippocampal NAAGergic neurons in experimental temporal lobe epilepsy , 2007, Brain Research.

[28]  G. Barker,et al.  Proton magnetic resonance spectroscopy of malformations of cortical development causing epilepsy , 2007, Epilepsy Research.

[29]  Rolf Gruetter,et al.  Neurochemical changes in Huntington R6/2 mouse striatum detected by in vivo1H NMR spectroscopy , 2007, Journal of neurochemistry.

[30]  R. D. O'Shea,et al.  Transporters for L‐glutamate: An update on their molecular pharmacology and pathological involvement , 2007, British journal of pharmacology.

[31]  Morris H. Baslow,et al.  2-PMPA, a NAAG peptidase inhibitor, attenuates magnetic resonance BOLD signals in brain of anesthetized mice , 2007, Journal of Molecular Neuroscience.

[32]  D. Cleveland,et al.  ALS: A Disease of Motor Neurons and Their Nonneuronal Neighbors , 2006, Neuron.

[33]  Douglas L. Rothman,et al.  Preliminary evidence of reduced occipital GABA concentrations in puerperal women: a 1H-MRS study , 2006, Psychopharmacology.

[34]  Rolf Gruetter,et al.  Proton MRS of the unilateral substantia nigra in the human brain at 4 tesla: Detection of high GABA concentrations , 2006, Magnetic resonance in medicine.

[35]  P. Williamson,et al.  Brain magnetic resonance spectroscopy in Tourette's disorder. , 2005, Journal of the American Academy of Child and Adolescent Psychiatry.

[36]  Clifford R Jack,et al.  Monitoring disease progression in transgenic mouse models of Alzheimer's disease with proton magnetic resonance spectroscopy. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[37]  J. Coyle,et al.  NAAG Reduces NMDA Receptor Current in CA1 Hippocampal Pyramidal Neurons of Acute Slices and Dissociated Neurons , 2005, Neuropsychopharmacology.

[38]  Piotr Czapiński,et al.  Mechanisms of action of antiepileptic drugs. , 2005, Current topics in medicinal chemistry.

[39]  J. Neale,et al.  Biosynthesis of NAAG by an enzyme‐mediated process in rat central nervous system neurons and glia , 2004, Journal of neurochemistry.

[40]  A. Schousboe,et al.  Developmental change of endogenous glutamate and gamma-glutamyl transferase in cultured cerebral cortical interneurons and cerebellar granule cells, and in mouse cerebral cortex and cerebellum in vivo , 1985, Neurochemical Research.

[41]  John S Duncan,et al.  Proton MRS reveals frontal lobe metabolite abnormalities in idiopathic generalized epilepsy , 2003, Neurology.

[42]  Pierre J Magistretti,et al.  GABA uptake into astrocytes is not associated with significant metabolic cost: Implications for brain imaging of inhibitory transmission , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[43]  M. Rijpkema,et al.  Characterization of oligodendrogliomas using short echo time 1H MR spectroscopic imaging , 2003, NMR in biomedicine.

[44]  K. Abe,et al.  Proton MR spectroscopic study at 3 Tesla on glutamate/glutamine in Alzheimer's disease , 2002, Neuroreport.

[45]  S. Laughlin,et al.  An Energy Budget for Signaling in the Grey Matter of the Brain , 2001, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[46]  R. Mattson,et al.  Topiramate Rapidly Raises Brain GABA in Epilepsy Patients , 2001, Epilepsia.

[47]  P. Antuono,et al.  Decreased glutamate + glutamine in Alzheimer’s disease detected in vivo with 1H-MRS at 0.5 T , 2001, Neurology.

[48]  Ana Gadea,et al.  Glial transporters for glutamate, glycine and GABA I. Glutamate transporters , 2001, Journal of neuroscience research.

[49]  E. Cherubini,et al.  Generating diversity at GAB Aergic synapses , 2001, Trends in Neurosciences.

[50]  B. Weber,et al.  Effects of Vigabatrin on Brain GABA+/CR Signals in Patients with Epilepsy Monitored by 1H‐NMR‐Spectroscopy: Responder Characteristics , 2001, Epilepsia.

[51]  A. López-Colomé,et al.  Glial transporters for glutamate, glycine, and GABA: II. GABA transporters , 2001, Journal of neuroscience research.

[52]  E. Cherubini,et al.  Generating diversity at GABAergic synapses. , 2001, Trends in neurosciences.

[53]  G. Moore,et al.  Evidence for Coupling between Glucose Metabolism and Glutamate Cycling Using FDG PET and 1H Magnetic Resonance Spectroscopy in Patients with Epilepsy , 2000, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[54]  A. Chapman,et al.  Glutamate and epilepsy. , 2000, The Journal of nutrition.

[55]  R. Shulman,et al.  Determination of the rate of the glutamate/glutamine cycle in the human brain by in vivo 13C NMR. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[56]  D L Rothman,et al.  Acute Effects of Vigabatrin on Brain GABA and Homocarnosine in Patients with Complex Partial Seizures , 1999, Epilepsia.

[57]  J S Duncan,et al.  Short echo time single‐voxel 1H magnetic resonance spectroscopy in magnetic resonance imaging–negative temporal lobe epilepsy: Different biochemical profile compared with hippocampal sclerosis , 1999, Annals of neurology.

[58]  M. Santi,et al.  N‐acetylaspartylglutamate activates cyclic AMP‐coupled metabotropic glutamate receptors in cerebellar astrocytes , 1998, Glia.

[59]  Prof. Dr. Dr. Valentino Braitenberg,et al.  Cortex: Statistics and Geometry of Neuronal Connectivity , 1998, Springer Berlin Heidelberg.

[60]  R. Shulman,et al.  Stoichiometric coupling of brain glucose metabolism and glutamatergic neuronal activity. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[61]  J. Frahm,et al.  Differential distribution of NAA and NAAG in human brain as determined by quantitative localized proton MRS , 1997, NMR in biomedicine.

[62]  J. Pin,et al.  Pharmacology and functions of metabotropic glutamate receptors. , 1997, Annual review of pharmacology and toxicology.

[63]  R. Mattson,et al.  Low brain GABA level is associated with poor seizure control , 1996, Annals of neurology.

[64]  P. Magistretti,et al.  Glutamate uptake into astrocytes stimulates aerobic glycolysis: a mechanism coupling neuronal activity to glucose utilization. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[65]  C R Houser,et al.  Comparative localization of two forms of glutamic acid decarboxylase and their mRNAs in rat brain supports the concept of functional differences between the forms , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[66]  S. Provencher Estimation of metabolite concentrations from localized in vivo proton NMR spectra , 1993, Magnetic resonance in medicine.

[67]  K. Rimvall,et al.  Regulation of γ‐Aminobutyric Acid Synthesis in the Brain , 1993 .

[68]  D. L. Martin,et al.  Regulation of gamma-aminobutyric acid synthesis in the brain. , 1993, Journal of neurochemistry.

[69]  J. Meyerhoff,et al.  Activity of a NAAG-hydrolyzing enzyme in brain may affect seizure susceptibility in genetically epilepsy-prone rats. , 1992, Epilepsy research. Supplement.

[70]  Jeffrey D. Rothstein,et al.  Reductions in acidic amino acids andN-acetylaspartylglutamate in amyotrophic lateral sclerosis CNS , 1991, Brain Research.

[71]  J. Coyle,et al.  Abnormal excitatory amino acid metabolism in amyotrophic lateral sclerosis , 1990, Annals of neurology.

[72]  D. Garfinkel,et al.  A simulation study of brain compartments. Metabolism of glutamate and related substances in mouse brain. , 1971, The Biochemical journal.

[73]  T. Hayashi,et al.  A physiological study of epileptic seizures following cortical stimulation in animals and its application to human clinics. , 1952, The Japanese journal of physiology.